Philip Low
Founder at On Target Laboratories LLC
Philip Low active positions
Companies | Position | Start | End |
---|---|---|---|
Purdue University | Corporate Officer/Principal | 2009-10-19 | - |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. | Director/Board Member | 2019-12-31 | - |
Founder | - | - | |
On Target Laboratories LLC
On Target Laboratories LLC BiotechnologyHealth Technology On Target Laboratories LLC develops precise and innovative small molecules whose goal is to target and illuminate cancer and other diseased tissue. The company is headquartered in Northbrook, IL. | Chief Tech/Sci/R&D Officer | - | - |
Founder | - | - | |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Director/Board Member | - | - |
Founder | - | - |
Career history of Philip Low
Former positions of Philip Low
Companies | Position | Start | End |
---|---|---|---|
QUINCE THERAPEUTICS, INC. | Director/Board Member | 2022-05-18 | 2023-03-26 |
ENDOCYTE, INC. | Director/Board Member | 1995-12-05 | 2018-12-20 |
Chief Tech/Sci/R&D Officer | 1995-12-05 | 2018-12-20 | |
Founder | 1995-12-05 | 2018-12-20 | |
Eradivir, Inc.
Eradivir, Inc. BiotechnologyHealth Technology Eradivir, Inc. is a company that builds targeted therapeutics for infectious diseases. Eradivir spun out of a multi-year research and technology development program in Philip Low's lab in 2020. The company is based in West Lafayette, IN. The company has developed a universal platform against influenza and is now applying these technologies to SARS-CoV-2, the virus that causes COVID-19. The company was founded by Philip S. Low and Martin R. Low. | Founder | - | - |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
Training of Philip Low
Brigham Young University | Undergraduate Degree |
University of California San Diego | Doctorate Degree |
Statistics
International
United States | 11 |
Operational
Founder | 5 |
Director/Board Member | 4 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 7 |
Consumer Services | 4 |
Government | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
QUINCE THERAPEUTICS, INC. | Health Technology |
Private companies | 6 |
---|---|
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
Endocyte, Inc.
Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
Eradivir, Inc.
Eradivir, Inc. BiotechnologyHealth Technology Eradivir, Inc. is a company that builds targeted therapeutics for infectious diseases. Eradivir spun out of a multi-year research and technology development program in Philip Low's lab in 2020. The company is based in West Lafayette, IN. The company has developed a universal platform against influenza and is now applying these technologies to SARS-CoV-2, the virus that causes COVID-19. The company was founded by Philip S. Low and Martin R. Low. | Health Technology |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. | Health Technology |
On Target Laboratories LLC
On Target Laboratories LLC BiotechnologyHealth Technology On Target Laboratories LLC develops precise and innovative small molecules whose goal is to target and illuminate cancer and other diseased tissue. The company is headquartered in Northbrook, IL. | Health Technology |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Health Technology |
- Stock Market
- Insiders
- Philip Low
- Experience